Knowledge and Acceptance of COVID-19 Vaccination among Women of Reproductive Age Group
Background: The acceptability of COVID vaccine by reproductive age group women remains unknown. Hence the study was conducted to define the knowledge about the COVID-19 vaccine and its acceptance in a sample of women who were planning to get pregnant.
Method: This is a prospective study conducted at Chettinad Hospital and Research Institute, Chennai, India on 157 women of reproductive age group during August-September 2022. Data were collected using a face-to-face questionnaire administered to women who attended the Obstetrics and Gynaecology OPD. Data were analysed using SPSS.
Results: Of the 157 respondents, nearly half were in the age group of 20-32 years, and almost 72% of them were educated with the minimum qualification being higher secondary education. In the given study, 70.7% were urban and semi-urban residents and 29.3% were rural women. About 66% of them were employed and the rest were unemployed. Gravidity status showed no significant differences regarding awareness. Overall awareness was about 74.5% and acceptance was 70.7%.
Conclusion: Though women are aware of the vaccines, there is hesitancy prevailing. Literacy plays an important role in vaccine awareness and acceptance. Women of reproductive age should be made aware that the COVID vaccine is safe for use. The side effects, if any, will also be mostly minor. Although vaccine trials have not been conducted on pregnant women, the beneficial effects of vaccination far outweigh the negligible risk, if any, to the foetus and the women were made aware of this information.
How to cite this article:
Nandhini S, Kandasamy V. Knowledge and Acceptance of COVID-19 Vaccination among Women of Reproductive Age Group. Chettinad Health City Med J. 2023;12(1):45-50.
World Health Organization [Internet]. Coronavirus disease (COVID-19) pandemic; [cited 2022 Sep 4]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=CjwKCAiAgc-AhA7EiwAjevj6mGRzsdtzqbpPQn8DNH3x2WdMmdAG_RIGyG4xdUt4nKnXgMwoXdYRoCVDEQAvD_BwE
Our World in Data [Internet]. Coronavirus (COVID-19) vaccinations; [cited 2022 Sep 4]. Available from: https://ourworldindata.org/covid-vaccinations
European Centre for Disease Prevention and Control (ECDC) [Internet]. Overview of the implementation of COVID-19 vaccination strategies and deployment plans in EU/ EEA; [cited 2022 Sep 4]. Available from: https://www.ecdc.europa.eu/en/publications-data/overviewimplementation-covid-19-vaccination-strategies-andvaccine-deployment
Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KR, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021;21(2):e26-e35. [PubMed] [Google Scholar]
European Centre for Disease Prevention and Control (ECDC) [Internet]. Riss assessment: risk related to SARS-CoV-2 variants of concern in EU/EEA - first update; [cited 2022 Sep 4]. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-riskassessment-spread-new-variants-concern-eueea-firstupdate?fbclid=IwAR0UPcRtV6JOyTu3vCOICv3KOgQneGJ_Uyw3XBQbNe2TvaReFcaDnKX21Bc
World Health Organisation [Internet]. Coronavirus disease (COVID-19) dashboard; [cited 2022 Sep 8]. Available from: https://covid19.who.int/?gclid=CjwKCAiAgc-ABhA7EiwAjev-jyX27VnkHYh_Muqsztk1IApJ2DI8LWEyMneN01KfS4x_H3Z_JtbMZxoC_8sQAvD_BwE
European Centre for Disease Prevention and Control (ECDC) [Internet]. Prevention and control of COVID-19 in long-term care facilities; [cited 2022 Sep 5]. Available from: https://www.ecdc.europa.eu/en/all-topics-z/coronavirus/threats-and-outbreaks/covid-19/prevention-and-control/LTCF
Kluge HH. Statement – update on COVID-19: the pandemic paradox: hope and hardship, in equal measure [Internet]. World Health Organisation; 2021 Jan [cited 2022 Sep 5]. Available from: https://www.who.int/europe/news/item/27-01-2021-statement-update-on-covid-19-the-pandemic-paradox-hope-andhardship-in-equal-measure
Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583-4. [PubMed] [Google Scholar]
Ashby B, Best A. Herd immunity. Curr Biol. 2021;31(4):R174-7. [PubMed] [Google Scholar]
MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161-4. [PubMed] [Google Scholar]
Chou WS, Gaysynsky A, Vanderpool RC. The COVID-19 misinfodemic: moving beyond fact-checking. Health Educ Behav. 2021;48(1):9-13. [PubMed] [Google Scholar]
Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res. 2009;11(1):e11. [PubMed] [Google Scholar]
World Health Organisation [Internet]. Early AI supported Response with Social Listening (EARS); [cited 2022 Sep 5]. Available from: https://www.who-ears.com/#/
World Health Organisation [Internet]. 1st WHO infodemic manager training; 2020 Nov [cited 2022 Sep 9]. Available from: https://www.who.int/teams/risk
Cordina M, Lauri MA, Lauri J. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine. Pharm Pract (Granada). 2021;19(1):2317. [PubMed] [Google Scholar]
Bhartiya S, Kumar N, Singh T, Murugan S, Rajavel S, Wadhwani M. Knowledge, attitude and practice towards COVID-19 vaccination acceptance in West India. Int J Community Med Public Health. 2021;8(3):1170-6. [Google Scholar]
Mose A, Yeshaneh A. COVID-19 vaccine acceptance and its associated factors among pregnant women attending antenatal care clinic in Southwest Ethiopia: institutional-based cross-sectional study. Int J Gen Med. 2021;14:2385-95. [PubMed] [Google Scholar]
Mannan KA, Farhana KM. Knowledge, attitude and acceptance of a COVID-19 vaccine: a global crosssectional study. Int Res J Bus Soc Sci. 2020 Dec 7;6(4). [Google Scholar]
Del Riccio M, Boccalini S, Rigon L, Biamonte MA, Albora G, Giorgetti D, Bonanni P, Bechini A. Factors influencing SARS-CoV-2 vaccine acceptance and hesitancy in a population-based sample in Italy. Vaccines (Basel). 2021 Jun 10;9(6):633. [PubMed] [Google Scholar]